Ask any of the countless people with substandard vision if there was one thing they could change about themselves and the typical response will be 20/20 vision. Betty Ming Liu, like most glasses-wearing individuals, had simply accepted the fuzzy side of life and continual degeneration of her eyes. Betty and her 20/650 vision had begun to additionally require the help of reading glasses to get by. She was less-than-enthused by the prospect of laser eye surgery.
By chance, Betty was introduced to holistic eye doctor Marc Grossman who opened her to the idea of eye exercises that promised to improve her vision. Within the Continue reading Myopic Patient Betty Ming Liu Benefits from Eye Exercises and Dr. Marc Grossman
A recent study linking cholesterol and macular degeneration may shed light on a highly significant problem caused by aging and potentially illuminates hope for a treatment or perhaps even a cure.
Macular degeneration is the leading cause in partial or complete blindness of adults over 60 in the United States. The disease targets the macula in eye which are a large part of how the eye perceives the fine detail allowing us do things like reading and driving.
A new study, published in the journal Cell Metabolism on April 2 2013, involved the study of macrophages from old mice and humans with macular degeneration. Macrophages, white blood cells that deconstruct cholesterol, have been found in higher than normal concentration in subjects with macular degeneration. In previous studies, this cellular build up has been shown Continue reading Macular Degeneration Treatment Sought in Anti-Cholesterol Drops
Researchers have found a layer of tissue in the eye that can self-renew and may provide cures in the future for retinal diseases such as Age-Related Macular Degeneration (ARMD), Stargardt’s disease, Best disease, and some types of retinitis pigmentosa. These eye diseases begin in the retinal pigment epithelium (RPE), which is a layer of eye tissue that supports the cells that make vision possible (photoreceptors). When the RPE degenerates, vision is compromised and can result in blindness.
Around ten percent of the cells in the RPE can renew themselves. In essence, they are dormant RPE stem cells. Cures for retinal diseases could lie in coaxing the dormant stem cells into becoming mature RPE cells. This could undo the damage from retinal diseases Continue reading Eye’s Stem Cells May Provide Key to ARMD, Retinitis Pigmentosa, Stargardt’s Disease
Researchers are looking into squalamine eye drops as a treatment for wet (neovascular) Age-Related Macular Degeneration (ARMD). Their goal is evaluate the safety and effectiveness of squalamine lactate eye drops in improving wet AMD, the less-common forms of AMD.
ARMD is a degenerative eye disease that causes central vision loss. It progresses over time and can results in significant vision loss. The disease is prevalent in the aging. This will be a double-blind study with randomized assignment, which is considered to be a very strong research design. It also means Continue reading Squalamine Eye Drops Clinical Trial for Wet Macular Degeneration (ARMD)
Researchers have found that the anti-diabetic drug metformin reduces the production of inflammatory cytokines. When inflammatory cytokines are produced in excess, they cause inflammation that increases cancer risk and the incidence of other diseases.
The University of Montreal researchers reported that metformin inhibits the expression of genes that code for several inflammatory cytokines observed during cellular senescence. These inflammatory cytokines are normally secreted by the Continue reading Diabetes Drug Metformin Anti-inflammatory Mechanism Discovered
CoQ10 deficiency and supplementation were explained in an article by Michael S. Pepper and his colleagues at the University of Pretoria in South Africa. The article in the March, 2013 issue of Nutrition Reviews covered both primary and secondary coenzyme Q10 (CoQ10) deficiency.
In primary CoQ10 deficiency, the body cannot properly synthesize CoQ10 because of genetic mutations. The gene sequences needed to produce the enzymes are incorrect.
Continue reading CoQ10 Deficiency and Supplementation of this Antioxidant
A study involving more than 2000 participants in Australia has shown an association between regular aspirin use and wet age-related macular degeneration (ARMD). The prospective analysis study involved four examinations over 15 years (1992-1994 to 2007-2009). Subjects filled in a questionnaire at the beginning of the study that recorded aspirin usage, heart disease and risk factors for ARMD. A retinal photograph was taken at each examination to determine whether subjects had wet (neovascular) ARMD and dry (geographic atrophy) ARMD.
Of all the subjects, 10.8% of them used aspirin regularly. The study results showed that they were more likely to develop wet ARMD (9.3% in aspirin users versus 3.7% in non-aspirin users). Even after adjusting for age, gender, smoking, history of Continue reading Aspirin Associated with Wet Age-Related Macular Degeneration (ARMD)
Based on a new research study done on mice, a simple drink of water laced with hydrogen gas–lactulose–might help prevent brain damage due to a stroke. The gas appears to protect cells from the after effects of oxygen starvation possibly by reacting with and disabling the post stroke toxic oxygen effects.
Continue reading Lactulose After a Stroke May Reduce Brain Damage
The Food and Drug Administration (FDA) has recommended that the block-buster sleeping pill Ambien (zolpidem) dose be lowered, especially for women, due to negative side-effects. The drug stays in women’s system much longer than in men’s. Too many car accidents the day after taking Ambien have lead to the government agency to halve the recommended dose for women, and re-consider the dose for men.
Continue reading Dose Size of Sleeping Pill Ambien Lowered Due to Negative Effects
The first implanted device for adults with retinitis pigmentosa has been approved by the U.S. Food and Drug Administration. Called the Argus II Retinal Prosthesis System, the device includes a tiny video camera, a transmitter (on a pair of glasses), and a video processing unit. The patient’s retina is replaced with a prosthesis. The camera wirelessly transmits visual information to the retinal prosthesis to improve vision.
Continue reading Retinitis Pigmentosa Argus II Retinal Prothesis FDA Approved